Phase 1/2 study in pediatric patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemia (BCP-ALL) receiving blinatumomab treatment Meeting Abstract


Authors: Von Stackelberg, A.; Locatelli, F.; Zugmaier, G.; Handgretinger, R.; Trippett, T. M.; Rizzari, C.; Zwaan, C. M.; Bhojwani, D.; DuBois, S. G.; Bader, P.; Borkhardt, A.; O'brien, M.; Rheingold, S. R.; Cooper, T. M.; Hu, K. L.; Mergen, N.; Fischer, A.; Zhu, M.; Hijazi, Y.; Whitlock, J.; Gore, L.
Abstract Title: Phase 1/2 study in pediatric patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemia (BCP-ALL) receiving blinatumomab treatment
Meeting Title: 56th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 124
Issue: 21
Meeting Dates: 2014 Dec 6-9
Meeting Location: San Francisco, CA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2014-12-06
Language: English
ACCESSION: WOS:000349242704056
PROVIDER: wos
Notes: Meeting Abstract: 3703 -- Source: Wos
MSK Authors